Bile Acid Diarrhea in Microscopic Colitis
Research output: Contribution to journal › Letter › Research › peer-review
Documents
- Fulltext
Final published version, 72.6 KB, PDF document
We read with great interest the study by Tome et al1 in which patients with microscopic colitis treated with bile acid sequestrants were identified in hospital registers and long-term efficacy assessed using retrospective data.
Several aspects of the response to treatment in the 282 patients included were unusual. Only 64% had responded to previous treatment with budesonide, which is lower than the 81% clinical response rate reported in clinical trials2 and a large-volume case series.3 This discrepancy probably is owing to a selection bias favoring budesonide nonresponders, as would be expected from the current study's design.1 Ninety patients were tested for bile acid diarrhea, of whom 51 (57% of the tested and 18% of the total cohort) had a positive test.
Several aspects of the response to treatment in the 282 patients included were unusual. Only 64% had responded to previous treatment with budesonide, which is lower than the 81% clinical response rate reported in clinical trials2 and a large-volume case series.3 This discrepancy probably is owing to a selection bias favoring budesonide nonresponders, as would be expected from the current study's design.1 Ninety patients were tested for bile acid diarrhea, of whom 51 (57% of the tested and 18% of the total cohort) had a positive test.
Original language | English |
---|---|
Journal | Clinical Gastroenterology and Hepatology |
Number of pages | 2 |
ISSN | 1542-3565 |
DOIs | |
Publication status | Accepted/In press - 2024 |
ID: 382982765